Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity

Podobne knjige/članki

• Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients
  od: Grandi, Tarciana, et al.
  Izdano: (2014)
• Tumor necrosis factor-α gene promoter −308 and −238 polymorphisms and its serum level in psoriasis
  od: Hagag, Magda M., et al.
  Izdano: (2021)
• Assessing tumor necrosis factor-α (-238 G/A and -308 G/A) genetic polymorphisms in sepsis susceptibility among cystic fibrosis patients
  od: Qahtan A. Mahdi, et al.
  Izdano: (2025-09-01)
• Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
  od: Mitchell, S, et al.
  Izdano: (2001)
• Polymorphism at position –308 of the tumour necrosis factor α gene and rheumatoid arthritis pharmacogenetics
  od: Fonseca, J, et al.
  Izdano: (2005)